[Retracted] Pan‐Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer

Xinming Song, Pintian Wang, Ruiling Feng, Mandika Chetry, E Li, Xiaohua Wu, Zewa Liu, Shasha Liao, Jing Lin

Open source

DOI
10.1155/2023/9349494
Published
2023-01
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2023/9349494,
  title = {[Retracted] Pan‐Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer},
  author = {Xinming Song and Pintian Wang and Ruiling Feng and Mandika Chetry and E Li and Xiaohua Wu and Zewa Liu and Shasha Liao and Jing Lin},
  year = {2023},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2023/9349494},
  url = {https://doi.org/10.1155/2023/9349494}
}

RIS

TY  - JOUR
TI  - [Retracted] Pan‐Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer
AU  - Xinming Song
AU  - Pintian Wang
AU  - Ruiling Feng
AU  - Mandika Chetry
AU  - E Li
AU  - Xiaohua Wu
AU  - Zewa Liu
AU  - Shasha Liao
AU  - Jing Lin
PY  - 2023
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2023/9349494
UR  - https://doi.org/10.1155/2023/9349494
ER  - 

APA

Song, X., Wang, P., Feng, R., Chetry, M., Li, E., Wu, X., Liu, Z., Liao, S., & Lin, J. (2023). [Retracted] Pan‐Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2023/9349494

Source records